Second generation
antipsychotics are useful for the treatment of
schizophrenia, but concerns have been raised about the side effects of
diabetes mellitus and
obesity.
Olanzapine, especially, is associated with more
weight gain than the others. It has been reported that
olanzapine promotes adipocyte-differentiation in rodents both in vivo and in vitro. In this study the effects of
antipsychotics on human adipocytes were investigated by using human mesenchymal stem cells (hMSCs). When hMSCs were differentiated and treated with various
antipsychotics,
olanzapine and
clozapine increased intracellular
lipids.
Olanzapine induced
lipid accumulation in a dose-dependent manner. Proteomic analysis revealed that PLIN4 and several
enzymes for lipid metabolism were increased in the hMSCs after
olanzapine treatment. During adipocyte differentiation,
olanzapine increased the
protein expression of PLIN1, PLIN2 and PLIN4. These
proteins are known to be associated with the initial stage of lipid droplet formation. Immunocytochemistry showed that
olanzapine increased and enlarged the lipid droplets coated with PLIN1 and PLIN2 while PLIN4 was largely distributed in the cytosol.
mRNA expression of PLIN2, but not PLIN1 or PLIN4, was increased by
olanzapine. On the other hand,
olanzapine did not alter the
mRNA level of transcription regulators involved in adipocyte-differentiation or
adipokines. The present study shows that
olanzapine induced transient PLIN2 expression in hMSCs that could result in an accumulation of lipid droplets and overexpression of PLIN1 and PLIN4, providing information of possible interest for
olanzapine-induced
weight gain.